Agents and Actions

, Volume 41, Supplement 2, pp C183–C184 | Cite as

Human endothelial cell responses to endotoxin are dramatically enhanced by human blood

  • J. Pugin
  • R. J. Ulevitch
  • P. S. Tobias
Proceedings of the Joint World Congress of the International Association of Inflammation Societies and the European Inflammation Society, Austria Center, Vienna, October 10–15, 1993 Cytokines, Therapeutic Targets in Inflammatory Diseases


Vascular endothelia activated by endotoxin (lipopolysaccharide, LPS) or cytokines actively participate in local and systemic inflammation such as those observed during Gram-negative sepsis, by secreting cytokines and chemokines, and upregulating adhesions molecules for blood leukocytes. LPS can directly activate endothelial cells via its interaction, with soluble CD14, but may also activate endothelial cell indirectly through LPS-induced, monocyte-derived cytokines. Here we show that the addition of blood cells to plasma rendered the endothelial cells sensitive to LPS concentrations 1000 times lower than when only plasma was present. We demonstrated that this effect was carried by monocytes and more precisely by soluble factors produced by monocytes, and they were further identified as tumor necrosis factor (TNF) and interleukin-1 (IL-1).


Endothelial Cell Blood Cell Tumor Necrosis Tumor Necrosis Factor Adhesion Molecule 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. [1]
    J. Pugin, C.-C. Schürer-Maly, D. Leturcq, A. Moriarty, R. J. Ulevitch and P. S. Tobias,Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA.90, 2744–2748 (1993).PubMedGoogle Scholar
  2. [2]
    E. A. Frey, D. S. Miller, T. Gullstein Jahr, A. Sundan, V. Bazil, T. Espevik, B. B. Finlay and S. D. Wright,Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med.173, 1665 (1992).CrossRefGoogle Scholar
  3. [3]
    M. Arditi, J. Zhou, R. Dorio, G. W. Rong, S. M. Goyert and K. S. Kim,Endotoxin-mediated endothelial cell injury and activation: Role of soluble CD14. Infect. and Immun.61, 3149–3156 (1993).Google Scholar
  4. [4]
    J. Pugin, R. J. Ulevitch and P. S. Tobias,A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation. J. Exp. Med.178, 2193–2200 (1993).CrossRefPubMedGoogle Scholar
  5. [5]
    S. J. H. van Deventer, H. R. Büller, J. W. ten Cate, A. Sturk and W. Pauw,Endotoxemia: An early predictor of septicemia in febrile patients. Lancet1, 605 (1988).PubMedGoogle Scholar
  6. [6]
    J. Pugin, R. J. Ulevitch and P. S. Tobias,Monocyte-derived TNF-α and IL-1β mediate endothelial cell activation in blood at low endotoxin concentrations (submitted).Google Scholar

Copyright information

© Birkhäuser Verlag 1994

Authors and Affiliations

  • J. Pugin
    • 1
  • R. J. Ulevitch
    • 1
  • P. S. Tobias
    • 1
  1. 1.Department of Immunology, IMM-12The Scripps Research InstituteLa JollaUSA

Personalised recommendations